Healthcare -
Biotechnology - NASDAQ - US
$ 13.55
0 %
$ 196 M
Market Cap
0.11
P/E
INBX - CAPITAL EXPENDITURES
Capital Expenditures INBX - Inhibrx Biosciences, Inc.
-4.59 M
LAST VALUE
-130.56%
2 YEAR CAGR
-26.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR